• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

质子磁共振波谱在乳腺中的应用:技术创新与临床应用。

Proton MR spectroscopy in the breast: Technical innovations and clinical applications.

机构信息

Department of Radiology, Breast Imaging Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Department of Biomedical Sciences and Morphologic and Functional Imaging, Policlinico Universitario G. Martino, University of Messina, Italy.

出版信息

J Magn Reson Imaging. 2019 Oct;50(4):1033-1046. doi: 10.1002/jmri.26700. Epub 2019 Mar 7.

DOI:10.1002/jmri.26700
PMID:30848037
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6732054/
Abstract

Proton magnetic resonance spectroscopy (MRS) is a promising noninvasive diagnostic technique for investigation of breast cancer metabolism. Spectroscopic imaging data may be obtained following contrast-enhanced MRI by applying the point-resolved spectroscopy sequence (PRESS) or the stimulated echo acquisition mode (STEAM) sequence from the MR voxel encompassing the breast lesion. Total choline signal (tCho) measured in vivo using either a qualitative or quantitative approach has been used as a diagnostic test in the workup of malignant breast lesions. In addition to tCho metabolites, other relevant metabolites, including multiple lipids, can be detected and monitored. MRS has been heavily investigated as an adjunct to morphologic and dynamic MRI to improve diagnostic accuracy in breast cancer, obviating unnecessary benign biopsies. Besides its use in the staging of breast cancer, other promising applications have been recently investigated, including the assessment of treatment response and therapy monitoring. This review provides guidance on spectroscopic acquisition and quantification methods and highlights current and evolving clinical applications of proton MRS. Level of Evidence 5 Technical Efficacy: Stage 5 J. Magn. Reson. Imaging 2019.

摘要

质子磁共振波谱(MRS)是一种很有前途的非侵入性诊断技术,可用于研究乳腺癌的代谢情况。在进行对比增强 MRI 后,可以通过在包含乳腺病变的 MR 体素中应用点分辨波谱序列(PRESS)或激发回波采集模式(STEAM)序列来获取光谱成像数据。使用定性或定量方法测量的总胆碱信号(tCho)已被用作恶性乳腺病变检查的诊断测试。除了 tCho 代谢物之外,还可以检测和监测其他相关代谢物,包括多种脂质。MRS 已被广泛研究作为形态学和动态 MRI 的辅助手段,以提高乳腺癌的诊断准确性,避免不必要的良性活检。除了在乳腺癌分期中的应用外,最近还研究了其他有前途的应用,包括治疗反应评估和治疗监测。本文综述了质子 MRS 的光谱采集和定量方法,并重点介绍了当前和不断发展的临床应用。证据水平 5 技术功效:第 5 阶段 J. 磁共振成像 2019 年。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a231/6732054/9008341a5f4f/nihms-1017858-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a231/6732054/2b5f59fe50ff/nihms-1017858-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a231/6732054/5623cd35c972/nihms-1017858-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a231/6732054/e200fa231163/nihms-1017858-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a231/6732054/2c64aeca0224/nihms-1017858-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a231/6732054/9008341a5f4f/nihms-1017858-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a231/6732054/2b5f59fe50ff/nihms-1017858-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a231/6732054/5623cd35c972/nihms-1017858-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a231/6732054/e200fa231163/nihms-1017858-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a231/6732054/2c64aeca0224/nihms-1017858-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a231/6732054/9008341a5f4f/nihms-1017858-f0005.jpg

相似文献

1
Proton MR spectroscopy in the breast: Technical innovations and clinical applications.质子磁共振波谱在乳腺中的应用:技术创新与临床应用。
J Magn Reson Imaging. 2019 Oct;50(4):1033-1046. doi: 10.1002/jmri.26700. Epub 2019 Mar 7.
2
Quantitative in vivo proton MR spectroscopic assessment of lipid metabolism: Value for breast cancer diagnosis and prognosis.定量活体质子磁共振波谱评估脂质代谢:用于乳腺癌诊断和预后的价值。
J Magn Reson Imaging. 2019 Jul;50(1):239-249. doi: 10.1002/jmri.26622. Epub 2019 Jan 3.
3
Diffusion Kurtosis at 3.0T as an in vivo Imaging Marker for Breast Cancer Characterization: Correlation With Prognostic Factors.3.0T 磁共振扩散峰度成像在乳腺癌特征性诊断中的应用:与预后因素的相关性研究
J Magn Reson Imaging. 2019 Mar;49(3):845-856. doi: 10.1002/jmri.26249. Epub 2018 Sep 8.
4
The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy.利用磁共振成像和质子磁共振波谱对人类乳腺病变进行评估。
Breast Cancer Res Treat. 2001 Jul;68(1):45-54. doi: 10.1023/a:1017911211090.
5
Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI.在 3T MRI 上使用单体素质子 MRS 对乳腺良恶性病变进行鉴别,可提高诊断准确性。
Clin Radiol. 2013 Sep;68(9):e502-10. doi: 10.1016/j.crad.2013.04.002. Epub 2013 May 23.
6
Role of diffusion weighted imaging and magnetic resonance spectroscopy in breast cancer patients with indeterminate dynamic contrast enhanced magnetic resonance imaging findings.弥散加权成像和磁共振波谱在动态对比增强磁共振成像结果不确定的乳腺癌患者中的作用。
Magn Reson Imaging. 2019 Sep;61:66-72. doi: 10.1016/j.mri.2019.05.032. Epub 2019 May 22.
7
Application value of 3T ¹H-magnetic resonance spectroscopy in diagnosing breast tumors.3T氢磁共振波谱在乳腺肿瘤诊断中的应用价值
Acta Radiol. 2013 May;54(4):380-8. doi: 10.1177/0284185113475921. Epub 2013 Apr 30.
8
Feasibility of MR spectroscopy for characterizing malignant breast lesions using a clinical 3-T scanner.使用临床3-T扫描仪通过磁共振波谱对乳腺恶性病变进行特征分析的可行性
Breast Cancer. 2015 Sep;22(5):510-9. doi: 10.1007/s12282-013-0514-y. Epub 2014 Jan 4.
9
H-MR spectroscopy of suspicious breast mass lesions at 3T: a clinical experience.3T 下乳腺可疑肿块病变的 H-MR 光谱:临床经验。
Radiol Med. 2017 Mar;122(3):161-170. doi: 10.1007/s11547-016-0713-7. Epub 2016 Dec 15.
10
Diffusion-Weighted Imaging-guided MR Spectroscopy in Breast Lesions using Readout-Segmented Echo-Planar Imaging.使用读出分段回波平面成像的扩散加权成像引导的乳腺病变磁共振波谱分析
Eur Radiol. 2016 Jun;26(6):1565-74. doi: 10.1007/s00330-015-4000-0. Epub 2015 Sep 19.

引用本文的文献

1
From lab to life: technological innovations in transforming cancer metastasis detection and therapy.从实验室到临床:癌症转移检测与治疗变革中的技术创新
Discov Oncol. 2025 Aug 10;16(1):1517. doi: 10.1007/s12672-025-02910-8.
2
Advances in breast cancer diagnosis: a comprehensive review of imaging, biosensors, and emerging wearable technologies.乳腺癌诊断的进展:影像学、生物传感器及新兴可穿戴技术的全面综述
Front Oncol. 2025 Jun 18;15:1587517. doi: 10.3389/fonc.2025.1587517. eCollection 2025.
3
Imaging cancer metabolism using magnetic resonance.

本文引用的文献

1
Quantitative in vivo proton MR spectroscopic assessment of lipid metabolism: Value for breast cancer diagnosis and prognosis.定量活体质子磁共振波谱评估脂质代谢:用于乳腺癌诊断和预后的价值。
J Magn Reson Imaging. 2019 Jul;50(1):239-249. doi: 10.1002/jmri.26622. Epub 2019 Jan 3.
2
Abbreviated MRI of the Breast: Does It Provide Value?乳腺磁共振成像缩写:它有价值吗?
J Magn Reson Imaging. 2019 Jun;49(7):e85-e100. doi: 10.1002/jmri.26291. Epub 2018 Sep 8.
3
Study of lipid metabolism by estimating the fat fraction in different breast tissues and in various breast tumor sub-types by in vivo H MR spectroscopy.
利用磁共振成像技术研究癌症代谢
Npj Imaging. 2024 Jan 11;2(1):1. doi: 10.1038/s44303-023-00004-0.
4
The Goldilocks Zone for 3-T MRS Studies Using Semi-LASER: Determining the Optimal Balance Between Repetition Time and Scan Time.使用半激光进行3-T磁共振波谱研究的适宜范围:确定重复时间与扫描时间之间的最佳平衡
NMR Biomed. 2025 Jul;38(7):e70064. doi: 10.1002/nbm.70064.
5
New progress in imaging diagnosis and immunotherapy of breast cancer.乳腺癌的影像诊断与免疫治疗新进展。
Front Immunol. 2025 Mar 17;16:1560257. doi: 10.3389/fimmu.2025.1560257. eCollection 2025.
6
Dynamic MRI with Locally Low-Rank Subspace Constraint: Towards 1-Second Temporal Resolution Aided by Deep Learning.具有局部低秩子空间约束的动态磁共振成像:借助深度学习迈向1秒时间分辨率
Res Sq. 2025 Feb 27:rs.3.rs-5448452. doi: 10.21203/rs.3.rs-5448452/v1.
7
New imaging techniques and trends in radiology.放射学中的新成像技术与趋势
Diagn Interv Radiol. 2025 Jan 16. doi: 10.4274/dir.2024.242926.
8
Prognostic significance of total choline on in-vivo proton MR spectroscopy for prediction of late recurrence in patients with hormone receptor-positive, HER2-negative early breast cancer.总胆碱在体内质子磁共振波谱分析中对激素受体阳性、HER2阴性早期乳腺癌患者晚期复发预测的预后意义
PLoS One. 2025 Jan 2;20(1):e0311012. doi: 10.1371/journal.pone.0311012. eCollection 2025.
9
Deuterium MR spectroscopy: potential applications in oncology research.氘磁共振波谱:在肿瘤学研究中的潜在应用。
BJR Open. 2024 Aug 5;6(1):tzae019. doi: 10.1093/bjro/tzae019. eCollection 2024 Jan.
10
Non-contrast Breast MR Imaging.乳腺非增强磁共振成像
Radiol Clin North Am. 2024 Jul;62(4):661-678. doi: 10.1016/j.rcl.2023.12.009. Epub 2024 Mar 7.
通过体内氢磁共振波谱法估计不同乳腺组织和各种乳腺肿瘤亚型中的脂肪分数来研究脂质代谢。
Magn Reson Imaging. 2018 Jun;49:116-122. doi: 10.1016/j.mri.2018.02.004. Epub 2018 Feb 14.
4
Fat Necrosis of the Breast: Magnetic Resonance Imaging Characteristics and Pathologic Correlation.乳房脂肪坏死:磁共振成像特征与病理相关性。
Acad Radiol. 2018 Aug;25(8):985-992. doi: 10.1016/j.acra.2017.12.019. Epub 2018 Feb 13.
5
Pre-surgical Multiparametric Assessment of Breast Lesions Using 3-Tesla Magnetic Resonance.使用3特斯拉磁共振对乳腺病变进行术前多参数评估
Anticancer Res. 2017 Dec;37(12):6965-6970. doi: 10.21873/anticanres.12163.
6
New diagnostic tools for breast cancer.乳腺癌的新型诊断工具。
Memo. 2017;10(3):175-180. doi: 10.1007/s12254-017-0341-5. Epub 2017 Jun 28.
7
Magnetic resonance metabolic profiling of estrogen receptor-positive breast cancer: correlation with currently used molecular markers.雌激素受体阳性乳腺癌的磁共振代谢谱分析:与当前使用的分子标志物的相关性
Oncotarget. 2017 Jun 28;8(38):63405-63416. doi: 10.18632/oncotarget.18822. eCollection 2017 Sep 8.
8
Impact of chemotherapy on metabolic reprogramming: Characterization of the metabolic profile of breast cancer MDA-MB-231 cells using H HR-MAS NMR spectroscopy.化疗对代谢重编程的影响:使用 H HR-MAS NMR 光谱学对乳腺癌 MDA-MB-231 细胞的代谢特征进行分析。
J Pharm Biomed Anal. 2017 Nov 30;146:324-328. doi: 10.1016/j.jpba.2017.08.038. Epub 2017 Sep 13.
9
A pilot evaluation of magnetic resonance imaging characteristics seen with solid papillary carcinomas of the breast in 4 patients.对4例乳腺实性乳头状癌的磁共振成像特征进行的初步评估。
BMC Cancer. 2017 Aug 7;17(1):525. doi: 10.1186/s12885-017-3518-8.
10
Predicting Neoadjuvant Chemotherapy in Nonconcentric Shrinkage Pattern of Breast Cancer Using 1H-Magnetic Resonance Spectroscopic Imaging.使用氢磁共振波谱成像预测乳腺癌非同心收缩模式下的新辅助化疗
J Comput Assist Tomogr. 2018 Jan/Feb;42(1):12-18. doi: 10.1097/RCT.0000000000000647.